Home Submit URL Add to Favorite Contact
           29 March, 2024
 
    
Business » Biotechnology and Pharmaceuticals » Pharmaceuticals » Biopharmaceuticals

UPDATE INFO | REPORT BROKEN LINK

MedImmune, Inc.

Popularity:    Hit: 1271
Details:
Develops, manufactures and markets formulations for use in immunization programs, including live virus vaccines. Includes patients guide to products, UK and US contacts, with investor relations and corporate communications in Gaithersburg, Maryland. (Nasdaq: AVIR)
URL: http://www.medimmune.com/
Title: MedImmune
Image:
Description: MedImmune, Inc.: dedicated to advances in biotechnology and devoted to patient support.
Specialized in: Biotechnology - Respiratory - Virus - Immune - Human

Related Sites 
Pharmos Corporation (Popularity: ): Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
Generex Biotechnology (Popularity: ): Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
Lybradyn: Microbial Natural Products (Popularity: ): Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation ...
Morphochem (Popularity: ): Focuses on finding therapeutic agents to treat diseases. Particular emphasis is on protein to protein interactions.
Modular Genetics, Inc. (Popularity: ): Supporting basic research, drug design, drug screening and chemical synthesis.
Myogen, Inc. (Popularity: ): Develops therapeutic drugs to treat heart failure using expertise in molecular cardiology and a human heart tissue bank. Includes product ...
Virax Holdings, Ltd. (Popularity: ): Developing therapeutics for autoimmune diseases, AIDS, cancers, infectious diseases based on patented Co-X-Gene platform technology co-expressing antibodies and T cells. ...
Vaccine and Infectious Disease Organization (Popularity: ): VIDO conducts research in immunization technology, offering partnership with manufacturers for livestock and humans. Includes project overview, patents and contract ...
ID Biomedical Corp. (Popularity: ): Develops proteosomes as delivery vehicles, with a gene-based testing platform for the identification of disease-causing bacteria from culture and other ...


Popular Sites
African Reptiles and Venom (Popularity: ): Supplier of snake venom for anti-serum production, with captive reptile breeding for pet trade. Offer film work, field tours, courses ...
Aphios Corp. (Popularity: ): Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product ...
Bavarian Nordic (Popularity: ): Developer and manufacturer offering prevention and treatment of infectious diseases, with pre-clinical research programs, and has established products for HIV ...
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
BioMarin Pharmaceutical Inc. (Popularity: ): Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria. Headquarters ...


Related Press
FDA Approves Vaccines for the 2010-2011 Influenza Season (Popularity: ): The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the ...